MKS Announces Launch of Series 49 Complete Thermal

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MKS Announces Launch of Series 49 Complete Thermal Management System

ANDOVER, Mass., Dec. 07, 2016 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI ), a global provider of technologies that enable advanced processes and improve productivity today announced the introduction of the S49 Thermal Management System. 

The Series 49 Thermal Management System features a choice of new main heater materials, an advanced heater controller and a simple user interface. Heaters are made from advanced materials that offer high energy efficiency, high operating temperatures and clean room compatibility. Heaters are available in Polyamide, the Series 49P heater, or Teflon, the Series 49T heater. The intelligent and flexible Series 49 Controller, with customized temperature operation, provides a complete, configurable thermal system management, and a new intuitive user interface enables quick and easy system access, control and diagnostics. The Series 49 is designed for numerous applications requiring precise temperature control including semiconductor manufacturing, analytical instrumentation, industrial coating, biopharmaceutical manufacturing and research applications.

Note to editors: To download a photo of the Series 49 System, please go to the MKS web site: http://www.mksinst.com/photos .

About MKS Instruments MKS Instruments, Inc. is a global provider of instruments, subsystems and process control solutions that measure, control, power, monitor and analyze critical parameters of advanced manufacturing processes to improve process performance and productivity. Our products are derived from our core competencies in pressure measurement and control, materials delivery, gas composition analysis, control and information technology, power and reactive gas generation, vacuum technology, photonics, optics, lasers and motion control. Our primary served markets are manufacturers of capital equipment for electronic thin film, process manufacturing, environmental monitoring and life sciences, as well as government and research.

Contact: MaryAnn Naddy maryann_naddy@mksinst.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 105

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 809

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 382

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 83

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 309

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 555

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 144

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 190

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 298

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 700

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Carter's P/E Ratio: Investor Insights Revealed

Updated Category News Views 189

Carter's Inc.: Analyzing the Current P/E Ratio Carter's Inc. (CRI) is currently trading at $23.70, observing a drop of 2.23% in its latest session. Over the preceding month, the stock has seen a significant decline of 24.72%, and an even steeper fall of 60.12% within the last year. This decline prompts long-term shareholders and potential investors to evaluate the...

Continue Reading
Planet Green Welcomes Dr. Raymond Goldie to Advisory Board

Updated Category News Views 170

Planet Green Welcomes Dr. Raymond Goldie to Its Advisory Board Planet Green Metals Inc. (CSE: PGR) is excited to announce that Dr. Raymond Goldie has officially joined the Company’s Advisory Board. Introducing Dr. Raymond Goldie Dr. Goldie currently serves as the President of the Prospectors and Developers Association of Canada. He is well-known for his engaging...

Continue Reading
Mabwell Showcases 7MW4811's Promising Pre-clinical Results

Updated Category News Views 136

Mabwell Unveils Exciting Pre-clinical Findings of 7MW4811 Mabwell (688062.SH) is an innovative biopharmaceutical company known for its efforts to revolutionize cancer treatment. Recently, Mabwell presented a compelling poster on the "Preclinical Development of 7MW4811, an Mtoxin™ (MF6)-based Antibody-drug Conjugate for the Treatment of Solid Tumors" at the esteemed...

Continue Reading
Apple's Juno App Removal Sparks Developer's Reaction

Updated Category News Views 216

Apple Takes Action Against Unofficial YouTube App for Vision Pro Recently, Apple Inc. (NASDAQ: AAPL) made the decision to remove Juno, an unofficial YouTube application crafted for the Vision Pro headset, from its App Store. This move follows a formal warning from Google, part of Alphabet Inc. (NASDAQ: GOOG) and GOOGL), emphasizing compliance with YouTube's guidelines....

Continue Reading
Understanding the Wayne Memorial Hospital Data Breach

Updated Category News Views 233

Overview of the Data Breach Incident In recent news, Wayne Memorial Hospital has disclosed a significant data breach that has affected a large number of individuals. This hospital, well-known for providing a wide array of medical services, encountered a cybersecurity incident that compromised a vast range of sensitive personal information. The hack involved unauthorized...

Continue Reading